Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

Hepatitis C virus infection among injection drug users with and without human immunodeficiency virus co-infection.

Hsieh MH, Tsai JJ, Hsieh MY, Huang CF, Yeh ML, Yang JF, Chang K, Lin WR, Lin CY, Chen TC, Huang JF, Dai CY, Yu ML, Chuang WL.

PLoS One. 2014 Apr 10;9(4):e94791. doi: 10.1371/journal.pone.0094791. eCollection 2014.

2.

Anti-HIV seropositivity was related to HBsAg seropositivity among injecting drug users in Taiwan.

Hsieh MH, Hsieh MY, Huang CF, Yeh ML, Wang SC, Yang JF, Chang K, Lin WR, Lin CY, Chen TC, Huang JF, Dai CY, Tsai JJ, Chuang WL, Yu ML.

Kaohsiung J Med Sci. 2016 Feb;32(2):96-102. doi: 10.1016/j.kjms.2016.01.008. Epub 2016 Feb 20.

3.

Hepatitis D virus infections among injecting drug users with and without human immunodeficiency virus infection in Taiwan.

Hsieh MH, Wang SC, Hsieh MY, Huang CF, Yeh ML, Yang JF, Chang K, Lin WR, Lin CY, Chen TC, Huang JF, Dai CY, Tsai JJ, Chuang WL, Yu ML.

Kaohsiung J Med Sci. 2016 Oct;32(10):526-530. doi: 10.1016/j.kjms.2016.08.004. Epub 2016 Sep 18.

4.

Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study.

Dong Y, Qiu C, Xia X, Wang J, Zhang H, Zhang X, Xu J.

Arch Virol. 2015 Apr;160(4):929-36. doi: 10.1007/s00705-014-2311-0. Epub 2015 Jan 24.

PMID:
25616842
5.

Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.

Chen X, He JM, Ding LS, Zhang GQ, Zou XB, Zheng J.

Arch Virol. 2013 Sep;158(9):1889-94. doi: 10.1007/s00705-013-1681-z. Epub 2013 Apr 4.

PMID:
23553454
6.

Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan.

Liu JY, Lin HH, Liu YC, Lee SS, Chen YL, Hung CC, Ko WC, Huang CK, Lai CH, Chen YS, Shih YL, Chung HC, Liang SH, Lin JN.

Clin Infect Dis. 2008 Jun 1;46(11):1761-8. doi: 10.1086/587992.

PMID:
18433337
7.

Study on the blood-borne virus co-infection and T lymphocyte subset among intravenous drug users.

Li JR, Gong RY, Tian KL, Wang J, Wang YX, Huang HJ.

World J Gastroenterol. 2007 Apr 28;13(16):2357-62.

8.

HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran.

Rahimi-Movaghar A, Razaghi EM, Sahimi-Izadian E, Amin-Esmaeili M.

Int J Infect Dis. 2010 Jan;14(1):e28-33. doi: 10.1016/j.ijid.2009.03.002. Epub 2009 May 21.

9.

Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.

Devi KhS, Brajachand N, Singh HL, Singh YM.

J Commun Dis. 2005 Mar;37(1):73-7.

PMID:
16637404
10.

Prevalences and associated risk factors of HCV/HIV co-infection and HCV mono-infection among injecting drug users in a methadone maintenance treatment program in Taipei, Taiwan.

Yen YF, Yen MY, Su LW, Li LH, Chuang P, Jiang XR, Deng CY.

BMC Public Health. 2012 Dec 11;12:1066. doi: 10.1186/1471-2458-12-1066.

11.

Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients.

Otegbayo JA, Taiwo BO, Akingbola TS, Odaibo GN, Adedapo KS, Penugonda S, Adewole IF, Olaleye DO, Murphy R, Kanki P.

Ann Hepatol. 2008 Apr-Jun;7(2):152-6.

PMID:
18626434
12.

Changing hepatitis D virus epidemiology in a hepatitis B virus endemic area with a national vaccination program.

Lin HH, Lee SS, Yu ML, Chang TT, Su CW, Hu BS, Chen YS, Huang CK, Lai CH, Lin JN, Wu JC.

Hepatology. 2015 Jun;61(6):1870-9. doi: 10.1002/hep.27742. Epub 2015 Apr 20.

PMID:
25677884
13.

Viral hepatitis and HIV infection among injection drug users in a central Iranian City.

Sofian M, Aghakhani A, Banifazl M, Azadmanesh K, Farazi AA, McFarland W, Eslamifar A, Ramezani A.

J Addict Med. 2012 Dec;6(4):292-6. doi: 10.1097/ADM.0b013e3182659928.

PMID:
22895463
14.

Seroprevalence of viral hepatitis and infectious complications among human immunodeficiency virus-infected injection drug users at a referral hospital.

Liang SH, Lo YC, Lin HH, Chang SY, Chen MY, Hsieh SM, Sheng WH, Sun HY, Hung CC, Chang SC.

J Microbiol Immunol Infect. 2008 Jun;41(3):200-8.

PMID:
18629414
15.

Coinfection with HIV and hepatitis C virus among injection drug users in southern China.

Garten RJ, Zhang J, Lai S, Liu W, Chen J, Yu XF.

Clin Infect Dis. 2005 Jul 1;41 Suppl 1:S18-24.

PMID:
16265609
16.

Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe.

Soriano V, Mocroft A, Rockstroh J, Ledergerber B, Knysz B, Chaplinskas S, Peters L, Karlsson A, Katlama C, Toro C, Kupfer B, Vogel M, Lundgren J; EuroSIDA Study Group..

J Infect Dis. 2008 Nov 1;198(9):1337-44. doi: 10.1086/592171.

PMID:
18767985
17.

Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain.

Santana Rodríguez OE, Malé Gil ML, HernándezSantana JF, Limiñana Cañal JM, Martín Sánchez AM.

Eur J Epidemiol. 1998 Sep;14(6):555-61.

PMID:
9794122
19.

Alarming epidemics of human immunodeficiency virus and hepatitis C virus among injection drug users in the northwestern bordering state of Punjab, India: prevalence and correlates.

Panda S, Roy T, Pahari S, Mehraa J, Sharma N, Singh G, Singh J, Joseph F, Singh S, Sharma NM.

Int J STD AIDS. 2014 Jul;25(8):596-606. doi: 10.1177/0956462413515659. Epub 2013 Dec 18.

PMID:
24352120
20.

Molecular epidemiology of HCV monoinfection and HIV/HCV coinfection in injection drug users in Liuzhou, Southern China.

Tan Y, Wei QH, Chen LJ, Chan PC, Lai WS, He ML, Kung HF, Lee SS.

PLoS One. 2008;3(10):e3608. doi: 10.1371/journal.pone.0003608. Epub 2008 Oct 31.

Supplemental Content

Support Center